Problems with certain Philips PAP and home ventilators

Based on the latest analysis of potential health risks and out of an abundance of caution, the Philips advises patients and customers to take the following actions:

• For patients using affected BiLevel PAP and CPAP devices: Discontinue use of your device and work with your physician or Durable Medical Equipment (DME) provider to determine the most appropriate options for continued treatment. To continue use of your device due to lack of alternatives, consult with your physician to determine if the benefit of continuing therapy with your device outweighs the risks identified in the recall notification.*
• For patients using affected life-sustaining mechanical ventilator devices: Do not stop or alter your prescribed therapy until you have talked to your physician. Philips recognizes that alternate ventilator options for therapy may not exist or may be severely limited for patients who require a ventilator for life-sustaining therapy, or in cases where therapy disruption is unacceptable. In these situations, and at the discretion of the treating clinical team, the benefit of continued usage of these ventilator devices may outweigh the risks identified in the recall notification.*

Please refer to Philips provides update on recall notification - News | Philips
You can read here which products are affected:

SLEEP PRODUCTS	RESPIRATORY PRODUCTS
DreamStation CPAP / APAP DreamStation BiPAP  DreamStation ASV DreamStation Go CPAP DreamStation Go APAP   OmniLab Advanced Plus (sleep lab) CPAP 50 Series CPAP 50 Series ASV 60 Series CPAP 60 Series ASV Dorma 400, Dorma 500, & REMStar SE Auto CPAP (value line)	DreamStation AVAPS/ST  C Series AVAPS/ST  A 40/30  Trilogy 100  Trilogy 200 V30 Auto (hospital use)  E30 (hospital use)

We are in discussions with Philips about further instructions on actions to be taken.

 *  This is a recall notification for the US only, and a field safety notice for the rest of the world.